NeoGenomics, Inc. (NEO)

NeoGenomics Market Cap

NeoGenomics has a market cap or net worth of $1.21 billion as of October 14, 2025. Its market cap has decreased by -35.59% in one year.

• Market Cap: 1.21B
• Enterprise Value: 1.48B
• 1-Year Change: -35.59%
• Ranking: #2396
• Category: Small-Cap
• Stock Price: $9.36

Market Cap Chart

Since March 16, 2004, NeoGenomics's market cap has increased from $7.90M to $1.21B, an increase of 15,197.04%. That is a compound annual growth rate of 26.23%.

Market Cap History

Date	Market Cap	% Change
Oct 13, 2025	1.21B	-42.97%
Dec 31, 2024	2.12B	2.57%
Dec 29, 2023	2.06B	76.73%
Dec 30, 2022	1.17B	-72.22%
Dec 31, 2021	4.20B	-29.72%
Dec 31, 2020	5.98B	95.74%
Dec 31, 2019	3.05B	160.37%
Dec 31, 2018	1.17B	64.64%
Dec 29, 2017	712.40M	5.87%
Dec 30, 2016	672.90M	41.66%
Dec 31, 2015	475.00M	89.92%
Dec 31, 2014	250.10M	41.06%
Dec 31, 2013	177.30M	57.88%
Dec 31, 2012	112.30M	85.62%
Dec 30, 2011	60.50M	24.49%
Dec 31, 2010	48.60M	-12.90%
Dec 31, 2009	55.80M	189.12%
Dec 31, 2008	19.30M	-43.07%
Dec 31, 2007	33.90M	-16.30%
Dec 29, 2006	40.50M	841.86%
Dec 30, 2005	4.30M	-20.37%
Dec 31, 2004	5.40M	-31.65%
Mar 16, 2004	7.90M	-

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	748.25B
Johnson & Johnson	459.32B
AbbVie	407.19B
UnitedHealth Group	321.06B
AstraZeneca	264.75B
Novo Nordisk	260.80B
Novartis AG	253.85B
Abbott Laboratories	230.73B